JP5409602B2 - 慢性疼痛の治療におけるジミラセタムの使用 - Google Patents

慢性疼痛の治療におけるジミラセタムの使用 Download PDF

Info

Publication number
JP5409602B2
JP5409602B2 JP2010503482A JP2010503482A JP5409602B2 JP 5409602 B2 JP5409602 B2 JP 5409602B2 JP 2010503482 A JP2010503482 A JP 2010503482A JP 2010503482 A JP2010503482 A JP 2010503482A JP 5409602 B2 JP5409602 B2 JP 5409602B2
Authority
JP
Japan
Prior art keywords
dimiracetam
pain
treatment
amounts ranging
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2010503482A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010524882A5 (enExample
JP2010524882A (ja
Inventor
ファリナ・カルロ
ゲラルディニ・カルラ
ペトリッロ・パオラ
Original Assignee
ニューロチェーン アクチェン ゲゼルシャフト
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ニューロチェーン アクチェン ゲゼルシャフト filed Critical ニューロチェーン アクチェン ゲゼルシャフト
Publication of JP2010524882A publication Critical patent/JP2010524882A/ja
Publication of JP2010524882A5 publication Critical patent/JP2010524882A5/ja
Application granted granted Critical
Publication of JP5409602B2 publication Critical patent/JP5409602B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2010503482A 2007-04-16 2008-04-15 慢性疼痛の治療におけるジミラセタムの使用 Active JP5409602B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI2007A000770 2007-04-16
IT000770A ITMI20070770A1 (it) 2007-04-16 2007-04-16 Impiego di dimiracetam nel trattamento del dolore cronico
PCT/EP2008/054553 WO2008125674A1 (en) 2007-04-16 2008-04-15 Use of dimiracetam in the treatment of chronic pain

Publications (3)

Publication Number Publication Date
JP2010524882A JP2010524882A (ja) 2010-07-22
JP2010524882A5 JP2010524882A5 (enExample) 2011-05-26
JP5409602B2 true JP5409602B2 (ja) 2014-02-05

Family

ID=39628738

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010503482A Active JP5409602B2 (ja) 2007-04-16 2008-04-15 慢性疼痛の治療におけるジミラセタムの使用

Country Status (15)

Country Link
US (2) US7989421B2 (enExample)
EP (3) EP2146706B1 (enExample)
JP (1) JP5409602B2 (enExample)
CN (2) CN103284997B (enExample)
AU (1) AU2008237901B2 (enExample)
BR (1) BRPI0810475A2 (enExample)
CA (1) CA2684363C (enExample)
EA (2) EA019354B1 (enExample)
ES (2) ES2584161T3 (enExample)
IL (2) IL201498A (enExample)
IT (1) ITMI20070770A1 (enExample)
MX (1) MX2009011380A (enExample)
PL (2) PL2857017T3 (enExample)
WO (1) WO2008125674A1 (enExample)
ZA (1) ZA200906991B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9125898B2 (en) 2008-11-14 2015-09-08 Neurotune Ag Acetam derivatives for pain relief
PL2598504T3 (pl) 2010-07-26 2014-10-31 Neurotune Ag Sposób otrzymywania dimiracetamu
EP2658540A1 (en) * 2010-10-29 2013-11-06 Neurotune AG Therapeutic use of dimiracetam to prevent the hand&foot syndrome caused by sorafenib
JPWO2012137645A1 (ja) * 2011-04-07 2014-07-28 旭化成ファーマ株式会社 抗癌剤に起因する異痛症の予防及び／又は治療剤
CN102743372B (zh) * 2012-06-30 2015-09-09 江苏省中医药研究院 一种化疗致血痹动物模型建立方法
JOP20190251A1 (ar) * 2017-05-31 2019-10-21 Metys Pharmaceuticals AG تركيبات تآزرية تشتمل على (r)-ديميراسيتام (1) و(s)-ديميراسيتام (2) بنسبة غير راسيمية
MX2020005310A (es) * 2017-11-21 2020-10-08 Medoncare Pharmaceutical Co Ltd Producto de combinacion que comprende dicicloplatino y metodo de preparacion y uso del mismo.
DE102019107619A1 (de) 2019-03-25 2020-10-01 Mondi Ag Verpackungsbeutel aus einem Kunststoffgewebeverbund
US11977085B1 (en) 2023-09-05 2024-05-07 Elan Ehrlich Date rape drug detection device and method of using same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3324219A1 (de) * 1983-07-05 1985-01-17 Hoechst Ag, 6230 Frankfurt Mehrlagige elektroisolierfolie
US5028595A (en) * 1987-09-18 1991-07-02 Hoffmann-La Roche Inc. Method for preventing AIDS in a subject or treating a subject infected with the AIDS virus
IT1233860B (it) 1988-02-08 1992-04-21 Isf Spa Derivati del peridroazacicloalca (1,2-a) imidazolo ad attivita' nootropa
GB9123641D0 (en) 1991-11-07 1992-01-02 Isf Spa Process
CA2392879C (en) * 1999-12-01 2005-03-29 Ucb, S.A. A pyrrolidineacetamide derivative alone or in combination for treatment of cns disorders
KR100823668B1 (ko) * 2000-12-28 2008-04-21 해밀턴 파마슈티컬스 인코포레이티드 신경성 통증 치료 및 예방약
ITMI20030573A1 (it) * 2003-03-24 2004-09-25 Nikem Research Srl Composti ad azione nootropica, loro preparazione,

Also Published As

Publication number Publication date
CA2684363A1 (en) 2008-10-23
PL2146706T3 (pl) 2015-07-31
US7989421B2 (en) 2011-08-02
PL2857017T3 (pl) 2016-11-30
EP2857017A2 (en) 2015-04-08
IL218851A (en) 2013-09-30
IL201498A (en) 2013-10-31
EA019354B1 (ru) 2014-03-31
EP2857017A3 (en) 2015-05-06
ES2536631T3 (es) 2015-05-27
EP2146706B1 (en) 2015-02-25
IL218851A0 (en) 2012-05-31
US20110251250A1 (en) 2011-10-13
EA022867B1 (ru) 2016-03-31
AU2008237901A1 (en) 2008-10-23
ZA200906991B (en) 2011-03-30
ES2584161T3 (es) 2016-09-26
AU2008237901B2 (en) 2013-06-27
CN101677984A (zh) 2010-03-24
EP2620149A2 (en) 2013-07-31
ITMI20070770A1 (it) 2008-10-17
EA200901237A1 (ru) 2010-04-30
EP2146706A1 (en) 2010-01-27
CN103284997B (zh) 2015-06-03
EP2620149A3 (en) 2013-08-07
US8222241B2 (en) 2012-07-17
HK1209053A1 (en) 2016-03-24
WO2008125674A1 (en) 2008-10-23
MX2009011380A (es) 2010-07-06
EA201300826A1 (ru) 2013-11-29
IL201498A0 (en) 2010-05-31
CA2684363C (en) 2016-02-09
BRPI0810475A2 (pt) 2015-10-20
US20100129469A1 (en) 2010-05-27
JP2010524882A (ja) 2010-07-22
CN103284997A (zh) 2013-09-11
EP2857017B1 (en) 2016-05-25

Similar Documents

Publication Publication Date Title
JP2010524882A (ja) 慢性疼痛の治療におけるジミラセタムの使用
KR20100014392A (ko) 섬유근통 치료용 드록시도파 및 약학 조성물
WO2000002542A2 (de) Mittel mit antidepressiver wirkung, enthaltend pramipexol und ein weiteres antidepressivum
HUE024558T2 (hu) Biotin alkalmazása szklerózis multiplex kezelésére
JP2007517049A (ja) 再発性病状を治療するための組成物および方法
CN112930183A (zh) 大麻二酚联合组合物
JP6116679B2 (ja) （１ｒ，４ｒ）−６’−フルオロ−Ｎ，Ｎ−ジメチル−４−フェニル−４’，９’−ジヒドロ−３’Ｈ−スピロ［シクロヘキサン−１，１’−ピラノ［３，４，ｂ］インドール］−４−アミンおよび抗けいれん剤を含む医薬組成物
WO2007054348A1 (de) Neue arzneimittel
KR102232198B1 (ko) 의약으로서 사용되기 위한 (r)-펄린돌 및 약학적으로 허용 가능한 그의 염
CN105250316B (zh) 一种含二联苯酚的抗癫痫药物组合
KR20250004041A (ko) 삼차 신경통 치료 및 그와 관련된 통증 감소에 사용하기 위한 트리메프라진
JP2024510021A (ja) タシピミジン製剤およびその使用
AU2012201853B2 (en) Use of dimiracetam in the treatment of chronic pain
JP7257091B2 (ja) 認知症の治療及び予防薬
HK1138500A (en) Use of dimiracetam in the treatment of chronic pain
JP2020525548A (ja) 炎症反応を伴う疼痛状態における鎮痛のための末梢限局的二重作用性κおよびδオピオイドアゴニスト
AU2012276476A1 (en) Pharmaceutical composition for treating premature ejaculation and method for treating premature ejaculation
JP2017088584A (ja) 医薬組成物
HK1187244A (en) Use of dimiracetam in the treatment of chronic pain
KR20180010475A (ko) Trpc3의 억제제를 유효성분으로 포함하는 가려움증 치료용 약제학적 조성물
NZ242863A (en) Pharmaceutical compositions comprising atipamezole[4-(2-ethyl-2,3-dihydro-1h-inden-2-yl)-1h-imidazole]
CZ20021629A3 (cs) Farmaceutický prostředek
HK1209053B (en) Use of dimiracetam in the treatment of chronic pain

Legal Events

Date Code Title Description
RD01 Notification of change of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7421

Effective date: 20110128

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20110128

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110407

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20110407

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130222

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130517

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130613

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130904

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20131004

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20131105

R150 Certificate of patent or registration of utility model

Ref document number: 5409602

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250